Sri Lanka PRD Product Registration Dossier Checklist

1. Key takeaways

The core materials of the Sri Lankan PRD (Product Registration Dossier) are shared by both application pathways. The common base set comprises the official application form, detailed product parameters, the manufacturer’s declaration of conformity, the CE certificate (where available), the European Union quality system certificate, the GHTF-format Summary Technical Documentation (STED), the Essential Principles Checklist, an ISO 14971 risk analysis report, a finished-product COA test report, product labels, the product brochure, and multilingual instructions for use. On top of this common base, additional product-specific documentation is added according to the attributes of the product, covering sterile devices, active devices, in vitro diagnostic devices (IVDs), and implantable devices. In other words, every application draws on the same foundation, and the differences between applications arise only from the technical attributes that trigger the supplementary materials. This means the assembly work can be planned in two clearly separated stages: first complete the base layer once per portfolio, then address the special layer product by product. Understanding this two-layer logic before assembling the dossier is the most reliable way to avoid avoidable back-and-forth with the regulator, because most deficiency notices can be predicted simply by listing which attributes apply to the device in question.

• The PRD base set is identical for both registration pathways and is defined in the official material list, so the same foundation can be prepared once and reused across a portfolio of registrations.
• Supplementary materials are triggered by product attributes — sterile, active, IVD, or implantable — and each attribute calls for its own dedicated technical evidence.
• The STED and the Essential Principles Checklist both follow GHTF specifications, which supports reuse of documentation already prepared for other markets under the GHTF or IMDRF framework.
• Multilingual instructions are part of the base set for all products, not an optional extra for selected categories, and they must therefore be budgeted for every submission.
• The dossier itself is assembled in a defined order: common documents first, then the FMSA section where applicable, then the PRD section.

2. Legal basis

The requirements below trace back to the official guidance document GL-034, which took effect on 2025-07-23 and governs the content of the registration dossier. Each row of the table corresponds to one element of the base set described in the takeaways, together with the applicable source.

3. Expert insights

Insight one: the checklist is a two-layer structure of base plus product-specific items. Companies often notice only the base layer and overlook the supplementary materials that must be appended according to product attributes. Sterile products need sterilisation validation and ethylene oxide residue data, active products need IEC electrical safety and EMC testing, and IVDs need a performance evaluation report — these are precisely the areas where assessment deficiencies most frequently arise. A dossier that is complete on the base layer but incomplete on the special layer will still generate a deficiency notice, so the supplementary layer deserves the same planning discipline as the base layer.

Insight two: both the STED and the Essential Principles Checklist are marked as GHTF specifications. This shows that at the technical documentation level Sri Lanka directly adopts the GHTF template system. For companies that have already prepared documentation under the GHTF or IMDRF framework for other markets, the cost of reuse is comparatively low. The templates, section structure, and expected content are familiar, which shortens the assembly work considerably compared with markets that impose fully local documentation formats.

Insight three: multilingual instructions are a base item, not an additional item. Because they appear within the common materials, every product needs them, not only home-use devices (home-use devices are additionally subject to the mandatory trilingual patient information leaflet, see Article 29 of this series). Treating the multilingual instruction requirement as optional is a common planning error, and it surfaces late in the process when it is most expensive to correct. Translations should therefore be commissioned at the same time as the technical writing of the STED, so that both can be reviewed together before submission.

A further observation concerns the application form itself: the guidance distinguishes between general devices, IVDs, and listed devices, each of which has its own form. Selecting the wrong form at intake delays the application before any technical review has even begun, so category confirmation belongs at the very start of the checklist, not at the end.

4. Practical recommendations

• Build the PRD as a two-column verification table: the left column lists the base common materials, the right column lists the product-specific materials appended according to the attributes of the product.
• Mark every item as required or conditional, and record the responsible party for each item (manufacturer, MAH, or third-party laboratory).
• Sign off every item individually before submission; this is the most effective way to compress the deficiency rate to a minimum.
• Check the supplementary layer first for sterile, active, IVD, and implantable products, since those are the attributes most likely to generate assessment deficiencies.

5. Verification checklist

• □ Official application form completed (correct category selected)
• □ Detailed product parameters compiled
• □ Manufacturer’s declaration of conformity obtained
• □ CE certificate and EU quality system certificate (where available) ready
• □ STED summary technical documentation compiled
• □ Essential Principles Checklist completed
• □ ISO 14971 risk analysis report issued
• □ Finished-product COA test report obtained
• □ Product labels, brochure, and multilingual instructions prepared

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com